MOMAID - Postpartum Recovery Supplement

Problem: Pregnancy and birth places increased stress on the pelvic floor leaving the muscles fatigued and weak. The risk of pelvic floor injury increases with each pregnancy, and it is also associated with age at first vaginal delivery. Regeneration of pelvic floor muscles is important to prevent pelvic floor disorders like incontinence, prolapse or sexual dysfunctions. Solution: MOMAID improves recovery of the pelvic floor function after delivery. It contains ingredients that promote the restoration of muscular injuries following birth. Target Group: Aimed to improve the recovery of the over-exerted, loose, or even injured muscles of pelvic floor and perineum, helping women from having incontinence and sexual dysfunctionalities later in life. MOMAID is recommended to new mothers from day one for twelve months after delivery. Existing Alternatives: Currently no preventative measure, nor pharmaceutical treatment is known to significantly decrease the rate of pelvic floor muscle injury during pregnancy and labor. There is however a thriving market for maternity food supplements worldwide. Patent: PHARMACEUTICAL COMPOSITION FOR POSTPARTUM RECOVERY AND TREATMENT OF PELVIC FLOOR DYSFUNCTION, Patent No.: WO/2020/074952, Publication date: 04/16/2020 link Clinical study: Clinical trial has indicated that the special composition of our supplement containing all three key ingredients (zinc, leucin and omega-3 fatty acid) in a unique ratio is responsible for the observed beneficial effects on pelvic floor recovery. Published on April 03, 2020 at Obstetrics & Gynecology Science 2020;63(3):305-314 Product: Packed in a paper box containing 28 sachets of daily doses. Zinc, Omega-3 and L-leucine. 2 tablets and 1 softgel capsule in one daily dose. Availability: MOMAID is commercially available in 4 EU countries, launching in 15 more EU countries and Vietnam in 2024.